Both in Pharmaceuticals
AnaptysBio vs Rapport Therapeutics
Over the past year ANAB returned +32.4% and RAPP returned −5.6%; their daily moves had a correlation of 0.25.
ANAB +32.4% RAPP −5.6%Growth of $1, one year, split-adjusted
| Metric | ANAB | RAPP |
|---|---|---|
| Price | $47.73 | $25.44 |
| Market cap | $1.43B | $1.43B |
| Today | +1.75% | +1.23% |
| 1 month | −3.0% | −21.0% |
| 6 months | −31.1% | −28.5% |
| Year to date | −1.5% | −16.2% |
| 1 year | +30.5% | −12.1% |
| Revenue growth (YoY) | −8.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −206.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.1× | 71.6× |
| Net cash | $286.5M | $436.1M |
| Dividend yield | — | — |
| Volatility (60d) | 41.0% | 79.5% |
| Short % of float | 30.6% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).